EYWA PHARMA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 08 Sept 2023)
What this means for you
Registered since 07 Mar 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87045793
- Registration number
- 5154512
- Mark type
- Stylized text
- Filed
- 20 May 2016
- Published for opposition
- 20 Dec 2016
- Registered
- 07 Mar 2017
- Attorney of record
- M. Scott Alprin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations for the prevention and/or treatment of Rheumatic disorders, Oncological diseases, Auto-immune diseases, endocrine disorders, reproductive diseases, hematologic diseases, neurological disorders, renal and urologic disorders, cardiovascular and lymphatic diseases, digestive disorders, musculoskeletal disorders, infectious diseases, pain conditions, pulmonary diseases and integumentary diseases
Owner
- EYWA PHARMA INC., SOUTH PLAINFIELD, NJ, US
- Eywa Pharma Pte. Ltd, Singapore, SG
- Eywa Pharma Pte. Ltd, Singapore, SG
- Eywa Pharma Pte. Ltd, Singapore, SG
Prosecution history
- 07 Mar 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 04 Jun 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 08 Sept 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 08 Sept 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Sept 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Mar 2023 — TEAS SECTION 8 & 15 RECEIVED
- 07 Mar 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Jun 2021 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 27 Nov 2018 — AMENDMENT UNDER SECTION 7 - PROCESSED
- 15 Nov 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Oct 2018 — TEAS SECTION 7 REQUEST RECEIVED
- 14 Sept 2018 — AMENDMENT UNDER SECTION 7 - PROCESSED
- 11 Sept 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Aug 2018 — TEAS SECTION 7 REQUEST RECEIVED
- 07 Mar 2017 — REGISTERED-PRINCIPAL REGISTER